Communiqués Quanterix Corporation

Actions

QTRX

US74766Q1013

Equipement et technologie médicale avancés

Marché Fermé - Nasdaq 22:00:00 28/09/2026			Varia. 5j.	Varia. 1 janv.
3,520 ^USD	+7,65%		+15,79%	-44,65%

25/09	Quanterix Corporation lance le kit de séquençage moléculaire par code-barres PhenoCode 2.0, confirme la livraison au quatrième trimestre des panels TIME et ADC multiplex, et ouvre le développement de panels ADC personnalisés	CI
14/09	Quanterix Corporation annonce la nomination du Dr Yuri Fesko au poste de Chief Medical Officer	CI

Communiqués

25/09	Quanterix Delivers on Spatial Biology Content Innovation Commitments at ESSB 2026	BU
17/09	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
14/09	Quanterix Names Dr. Yuri Fesko Chief Medical Officer	BU
10/08	Quanterix Releases Financial Results for the Second Quarter of 2026	BU
10/08	Quanterix Names Jim Gute Chief Commercial Officer	BU
06/08	Quanterix To Participate in Canaccord Genuity Capital Markets 46th Annual Growth Conference on August 11-12	BU
04/08	Quanterix To Report Second Quarter 2026 Financial Results on August 10, 2026	BU
16/07	Quanterix Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	BU
14/07	Anthem Blue Cross and Blue Shield Establishes Commercial Coverage for LucentAD® Complete; Quanterix to Present New Data Highlighting Multi-Analyte Advantages	BU
16/06	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
09/06	Quanterix Announces Appointment of Jason Faessler as Chief Financial Officer	BU
04/06	Quanterix Appoints Industry Veteran Geoff Albrecht as Senior Vice President and General Manager of Diagnostics	BU
03/06	Quanterix To Participate in the Goldman Sachs 47th Annual Global Healthcare Conference	BU
26/05	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
12/05	Quanterix Announces Planned Transition of Chief Financial Officer	BU
06/05	Quanterix : Q1 2026 Earnings Call	PU
06/05	Quanterix : Q1-26 Earnings Presentation-FINAL	PU
06/05	Quanterix Releases Financial Results for the First Quarter of 2026	BU
06/05	Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer’s Biomarker Testing into Clinical Workflows	BU
27/04	Quanterix to Report First Quarter 2026 Financial Results on May 6, 2026	AQ
24/04	Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026	BU
17/04	AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology	BU
15/04	Quanterix Debuts Content Innovation Engine at AACR 2026	BU
27/03	Quanterix Corporation Announces Date of 2026 Annual Meeting	BU
02/03	Quanterix : Q4-25 Earnings Presentation-FINAL	PU